{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:46:48Z","timestamp":1792727208099,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T00:00:00Z","timestamp":1059696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T00:00:00Z","timestamp":1059696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.1124\/jpet.103.050286","type":"journal-article","created":{"date-parts":[[2003,7,18]],"date-time":"2003-07-18T23:17:37Z","timestamp":1058570257000},"page":"505-514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Continuous Administration of the 5-Hydroxytryptamine1A Agonist (3-Chloro-4-fluoro-phenyl)-[4-fluoro-4-{[(5-methyl-pyridin-2-ylmethyl) -amino]-methyl}piperidin-1-yl]-methadone (F 13640) Attenuates Allodynia-Like Behavior in a Rat Model of Trigeminal Neuropathic Pain"],"prefix":"10.1016","volume":"306","author":[{"given":"Kristof","family":"Deseure","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"Koek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Adriaensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis C.","family":"Colpaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.103.050286_bib1","doi-asserted-by":"crossref","unstructured":"Arn\u00e9r S and Meyerson B (1988) Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 33: 11\u201323.","DOI":"10.1016\/0304-3959(88)90198-4"},{"key":"10.1124\/jpet.103.050286_bib2","unstructured":"Attal N (2001) Pharmacologic treatment of neuropathic pain. Acta Neurol Belg 101: 53\u201364."},{"key":"10.1124\/jpet.103.050286_bib3","doi-asserted-by":"crossref","unstructured":"Attal N and Bouhassira D (1999) Mechanisms of pain in peripheral neuropathy. Acta Neurol Scand Suppl 173: 12\u201324.","DOI":"10.1111\/j.1600-0404.1999.tb07386.x"},{"key":"10.1124\/jpet.103.050286_bib4","doi-asserted-by":"crossref","unstructured":"Attal N, Chen YL, Kayser V, and Guilbaud G (1991) Behavioural evidence that systemic morphine may modulate a phasic pain-related behaviour in a rat model of peripheral mononeuropathy. Pain 47: 65\u201370.","DOI":"10.1016\/0304-3959(91)90012-M"},{"key":"10.1124\/jpet.103.050286_bib5","doi-asserted-by":"crossref","unstructured":"Barnes NM and Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38: 1083\u20131152.","DOI":"10.1016\/S0028-3908(99)00010-6"},{"key":"10.1124\/jpet.103.050286_bib6","doi-asserted-by":"crossref","unstructured":"Bennet GJ and Xie YK (1988) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33: 87\u2013107.","DOI":"10.1016\/0304-3959(88)90209-6"},{"key":"10.1124\/jpet.103.050286_bib7","doi-asserted-by":"crossref","unstructured":"Bruins Slot LA, Tarayre J-P, Koek W, Ribet J-P, and Colpaert FC (2002) Experimental conditions for the continuous subcutaneous infusion of central analgesia in rats. Pharmacol Biochem Behav 72: 943\u2013951.","DOI":"10.1016\/S0091-3057(02)00760-8"},{"key":"10.1124\/jpet.103.050286_bib8","doi-asserted-by":"crossref","unstructured":"Bulka A, Plesan A, Xu XJ, and Wiesenfeld-Hallin Z (2002) Reduced tolerance to the anti-hyperalgesic effect of methadone in comparison to morphine in a rat model of mononeuropathy. Pain 95: 103\u2013109.","DOI":"10.1016\/S0304-3959(01)00382-7"},{"key":"10.1124\/jpet.103.050286_bib9","unstructured":"Cesselin F, Laporte A-M, Miquel M-C, Bourgoin S, and Hamon M (1994) Serotonergic mechanisms of pain control, in Proceedings of the 7th World Congress on Pain, Progress in Pain Research and Management (Gebhart GF, Hammond DL, and Jensen TS eds) pp 669\u2013695, IASP Press, Seattle."},{"key":"10.1124\/jpet.103.050286_bib10","doi-asserted-by":"crossref","unstructured":"Christensen D, Gautron M, Guilbaud G, and Kayser V (1999) Combined systemic administration of the glycine\/NMDA receptor antagonist, (+)-HA966 and morphine attenuates pain-related behaviour in a rat model of trigeminal neuropathic pain. Pain 83: 433\u2013440.","DOI":"10.1016\/S0304-3959(99)00126-8"},{"key":"10.1124\/jpet.103.050286_bib11","doi-asserted-by":"crossref","unstructured":"Christensen D, Gautron M, Guilbaud G, and Kayser V (2001) Effect of gabapentin and lamotrigine on mechanical allodynia-like behaviour in a rat model of trigeminal neuropathic pain. Pain 93: 147\u2013153.","DOI":"10.1016\/S0304-3959(01)00305-0"},{"key":"10.1124\/jpet.103.050286_bib12","doi-asserted-by":"crossref","unstructured":"Clarke RW and Ward RE (2000) The role of 5-HT1A-receptors in fentanyl-induced bulbospinal inhibition of a spinal withdrawal reflex in the rabbit. Pain 85: 239\u2013245.","DOI":"10.1016\/S0304-3959(99)00272-9"},{"key":"10.1124\/jpet.103.050286_bib13","unstructured":"Colpaert FC (1978) Narcotic cue, narcotic analgesia and the tolerance problem: the regulation of sensitivity to drug cues and to pain by an internal cue processing model, in Stimulus Properties of Drugs: Ten Years of Progress (Colpaert FC and Rosecrans J eds) pp 301\u2013321, Elsevier\/North Holland Biomedical Press, Amsterdam."},{"key":"10.1124\/jpet.103.050286_bib14","doi-asserted-by":"crossref","unstructured":"Colpaert FC (1979) Can chronic pain be suppressed despite purported tolerance to narcotic analgesia? Life Sci 24: 1201\u20131210.","DOI":"10.1016\/0024-3205(79)90057-2"},{"key":"10.1124\/jpet.103.050286_bib15","doi-asserted-by":"crossref","unstructured":"Colpaert FC (1996) System theory of pain and of opiate analgesia: no tolerance to opiates. Pharmacol Rev 48: 355\u2013402.","DOI":"10.1016\/S0031-6997(25)06946-7"},{"key":"10.1124\/jpet.103.050286_bib16","doi-asserted-by":"crossref","unstructured":"Colpaert FC and Fr\u00e9gnac Y (2001) Paradoxical signal transduction in neurobiological systems. Mol Neurobiol 24: 145\u2013168.","DOI":"10.1385\/MN:24:1-3:145"},{"key":"10.1124\/jpet.103.050286_bib17","doi-asserted-by":"crossref","unstructured":"Colpaert FC, Niemegeers CJ, Janssen PA, and Maroli AN (1980) The effects of prior fentanyl administration and of pain on fentanyl analgesia: tolerance to and enhancement of narcotic analgesia. J Pharmacol Exp Ther 213: 418\u2013424.","DOI":"10.1016\/S0022-3565(25)32078-1"},{"key":"10.1124\/jpet.103.050286_bib18","doi-asserted-by":"crossref","unstructured":"Colpaert FC, Tarayre JP, Koek W, Pauwels PJ, Bardin L, Xu X-J, Wiesenfeld-Hallin Z, Cosi C, Carilla-Durand E, Assie MB, et al. (2002) Large amplitude 5-HT1A receptor activation: a new mechanism of profound central analgesia. Neuropharmacology 43: 945\u2013958.","DOI":"10.1016\/S0028-3908(02)00119-3"},{"key":"10.1124\/jpet.103.050286_bib19","unstructured":"DeMulder PA, Claus M, DeMulder G, Adriaensen H, and Vos BP (1994) Effects of morphine and ketamine on behavioral signs of increased trigeminal nociceptive activity after chronic constriction injury to the rat\u2019s infraorbital nerve. Soc Neurosci Abstr 20: 555."},{"key":"10.1124\/jpet.103.050286_bib20","doi-asserted-by":"crossref","unstructured":"Deseure K, Koek W, Colpaert FC, and Adriaensen H (2002) The 5-HT1A agonist F 13640 attenuates mechanical allodynia in a rat model of trigeminal neuropathic pain. Eur J Pharmacol 456: 51\u201357.","DOI":"10.1016\/S0014-2999(02)02640-7"},{"key":"10.1124\/jpet.103.050286_bib21","doi-asserted-by":"crossref","unstructured":"Gjerstad J, Tjolsen A, and Hole K (1996) The effect of 5-HT1A receptor stimulation on nociceptive dorsal horn neurones in rats. Eur J Pharmacol 318: 315\u2013321.","DOI":"10.1016\/S0014-2999(96)00819-9"},{"key":"10.1124\/jpet.103.050286_bib22","doi-asserted-by":"crossref","unstructured":"Gregg JM (1973) A surgical approach to the ophthalmic-maxillary nerve trunks in the rat. J Dent Res 52: 392.","DOI":"10.1177\/00220345730520024001"},{"key":"10.1124\/jpet.103.050286_bib23","doi-asserted-by":"crossref","unstructured":"Gunn AJ and Gunn TR (1998) The \u201cpharmacology\u201d of neuronal rescue with cerebral hypothermia. Early Hum Dev 53: 19\u201335.","DOI":"10.1016\/S0378-3782(98)00033-4"},{"key":"10.1124\/jpet.103.050286_bib24","unstructured":"Hamon M and Bourgoin S (1999) Serotonin and its receptors in pain control, in Novel Aspects of Pain Management: Opioids and Beyond (Sawynok J and Cowan A eds) pp 203\u2013228, Wiley-Liss, NY."},{"key":"10.1124\/jpet.103.050286_bib25","doi-asserted-by":"crossref","unstructured":"Id\u00e4np\u00e4\u00e4n-Heikkil\u00e4 JJ and Guilbaud G (1999) Pharmacological studies on a rat model of trigeminal neuropathic pain: baclofen, but not carbamazepine, morphine or tricyclic antidepressants, attenuates the allodynia-like behaviour. Pain 79: 281\u2013290.","DOI":"10.1016\/S0304-3959(98)00172-9"},{"key":"10.1124\/jpet.103.050286_bib26","doi-asserted-by":"crossref","unstructured":"Jacquin MF and Zeigler HP (1983) Trigeminal orosensation and ingestive behavior in the rat. Behav Neurosci 97: 62\u201397.","DOI":"10.1037\/\/0735-7044.97.1.62"},{"key":"10.1124\/jpet.103.050286_bib27","doi-asserted-by":"crossref","unstructured":"Jensen TS (2002) An improved understanding of neuropathic pain. Eur J Pain 6 (Suppl B): 3\u201311.","DOI":"10.1016\/S1090-3801(02)90002-9"},{"key":"10.1124\/jpet.103.050286_bib28","doi-asserted-by":"crossref","unstructured":"Ji RR and Woolf CJ (2001) Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain. Neurobiol Dis 8: 1\u201310.","DOI":"10.1006\/nbdi.2000.0360"},{"key":"10.1124\/jpet.103.050286_bib29","doi-asserted-by":"crossref","unstructured":"Kayser V, Aubel B, Hamon M, and Bourgoin S (2002) The antimigraine 5-HT(1B\/1D) receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behavior in a rat model of trigeminal neuropathic pain. Br J Pharmacol 137: 1287\u20131297.","DOI":"10.1038\/sj.bjp.0704979"},{"key":"10.1124\/jpet.103.050286_bib30","doi-asserted-by":"crossref","unstructured":"Koek W, Vacher B, Cosi C, Assie MB, Patoiseau JF, Pauwels PJ, and Colpaert FC (2001) 5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential. Eur J Pharmacol 420: 103\u2013112.","DOI":"10.1016\/S0014-2999(01)01011-1"},{"key":"10.1124\/jpet.103.050286_bib31","doi-asserted-by":"crossref","unstructured":"Marsala M, Vanicky I, and Yaksh TL (1994) Effect of graded hypothermia (27 degrees to 34 degrees C) on behavioral function, histopathology, and spinal blood flow after spinal ischemia in rat. Stroke 25: 2038\u20132046.","DOI":"10.1161\/01.STR.25.10.2038"},{"key":"10.1124\/jpet.103.050286_bib32","doi-asserted-by":"crossref","unstructured":"Millan MJ (1995) Serotonin (5-HT) and pain: a reappraisal of its role in the light of receptor multiplicity. Semin Neurosci 7: 409\u2013419.","DOI":"10.1016\/1044-5765(95)90005-5"},{"key":"10.1124\/jpet.103.050286_bib33","doi-asserted-by":"crossref","unstructured":"Ollat H and Cesaro P (1995) Pharmacology of neuropathic pain. Clin Neuropharmacol 18: 391\u2013404.","DOI":"10.1097\/00002826-199510000-00002"},{"key":"10.1124\/jpet.103.050286_bib34","unstructured":"Ossipov MH, Lai J, Malan TP, and Porreca F (1999) Opioid analgesic activity in neuropathic pain states, in Opioid Sensitivity of Chronic Noncancer Pain, Progress in Pain Research and Management (Kalso E, McQuay J, and Wiesenfeld-Hallin Z eds) vol 14, pp 163\u2013182, IASP Press, Seattle."},{"key":"10.1124\/jpet.103.050286_bib35","doi-asserted-by":"crossref","unstructured":"Portenoy RK, Foley KM, and Inturrisi CE (1990) The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions. Pain 43: 273\u2013286.","DOI":"10.1016\/0304-3959(90)90025-9"},{"key":"10.1124\/jpet.103.050286_bib36","unstructured":"Randall LO and Selitto JJ (1957) A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther 61: 409\u2013417."},{"key":"10.1124\/jpet.103.050286_bib37","doi-asserted-by":"crossref","unstructured":"Sindrup SH and Jensen TS (1999) Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 83: 389\u2013400.","DOI":"10.1016\/S0304-3959(99)00154-2"},{"key":"10.1124\/jpet.103.050286_bib38","doi-asserted-by":"crossref","unstructured":"Sindrup SH and Jensen TS (2002) Pharmacotherapy of trigeminal neuralgia. Clin J Pain 18: 22\u201327.","DOI":"10.1097\/00002508-200201000-00004"},{"key":"10.1124\/jpet.103.050286_bib39","unstructured":"Uchiyama Y, Okuno S, Nakase H, Sakaki T, Inoue T, and Koyama M (2001) Experimental study of pharmacological hypothermia: enhanced neuroprotective effect of a novel 5-HT 1 A agonist SUN N4057 by the pharmacological hypothermia. No To Shinkei 53: 853\u2013858."},{"key":"10.1124\/jpet.103.050286_bib40","unstructured":"Villanueva L and Le Bars D (1995) The activation of bulbo-spinal controls by peripheral nociceptive inputs: diffuse noxious inhibitory controls. Biol Res 28: 113\u2013125."},{"key":"10.1124\/jpet.103.050286_bib41","doi-asserted-by":"crossref","unstructured":"Vos BP, Strassman AM, and Maciewicz RJ (1994) Behavioral evidence of trigeminal neuropathic pain following chronic constriction injury to the rat\u2019s infraorbital nerve. J Neurosci 14: 2708\u20132723.","DOI":"10.1523\/JNEUROSCI.14-05-02708.1994"},{"key":"10.1124\/jpet.103.050286_bib42","unstructured":"Xu X-J, Yu W, Hao J-X, H\u00f6kfelt T, and Wiesenfeld-Hallin Z (1999) Opioid sensitivity in experimental central pain after spinal cord injury in rats, in Opioid Sensitivity of Chronic Noncancer Pain, Progress in Pain Research and Management (Kalso E, McQuay J, and Wiesenfeld-Hallin Z eds) vol 14, pp 183\u2013200, IASP Press, Seattle."},{"key":"10.1124\/jpet.103.050286_bib43","doi-asserted-by":"crossref","unstructured":"Zemlan FP, Murphy AZ, and Behbehani MM (1994) 5-HT1A receptors mediate the effect of the bulbospinal serotonin system on spinal dorsal horn nociceptive neurons. Pharmacology 48: 1\u201310.","DOI":"10.1159\/000139156"},{"key":"10.1124\/jpet.103.050286_bib44","doi-asserted-by":"crossref","unstructured":"Zimmerman M (2001) Pathobiology of neuropathic pain. Eur J Pharmacol 429: 23\u201327.","DOI":"10.1016\/S0014-2999(01)01303-6"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524308304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524308304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.103.050286","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:06:48Z","timestamp":1739970408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524308304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,8]]}},"alternative-id":["S0022356524308304"],"URL":"https:\/\/doi.org\/10.1124\/jpet.103.050286","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2003,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Continuous Administration of the 5-Hydroxytryptamine1A Agonist (3-Chloro-4-fluoro-phenyl)-[4-fluoro-4-{[(5-methyl-pyridin-2-ylmethyl) -amino]-methyl}piperidin-1-yl]-methadone (F 13640) Attenuates Allodynia-Like Behavior in a Rat Model of Trigeminal Neuropathic Pain","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.103.050286","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2003 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}